July 31, 2025

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Unpacking a Potential 183% Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing the attention of investors with its innovative approach in the biotechnology sector and an impressive potential upside. As a clinical-stage biotech firm, Cartesian..

Agora, Inc. (API) Stock Analysis: Navigating a 55.93% Potential Upside in the Tech Sector

Agora, Inc. (NASDAQ: API) presents an intriguing opportunity for investors with a notable potential upside of 55.93%, according to the average analyst target price of $6.05. As a key player..

ClearPoint Neuro Inc. (CLPT): Investor Outlook on a 172% Potential Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a key player in the healthcare sector’s medical device industry, is capturing investor attention with a remarkable potential upside of 172.05%. With a current market..

National Research Corporation (NRC) Stock Analysis: Understanding the Healthcare Insights Powerhouse Despite Valuation Challenges

National Research Corporation (NASDAQ: NRC), a key player in the healthcare sector, specializes in providing crucial analytics and insights to improve patient and employee experiences within healthcare organizations. Headquartered in..

Adobe Inc. (ADBE) Stock Analysis: Exploring the 32% Potential Upside for Investors

Adobe Inc. (NASDAQ: ADBE) stands as a titan in the technology sector, particularly within the software application industry. With a robust market capitalization of $154.41 billion, Adobe has cemented its..

Donnelley Financial Solutions (DFIN) Stock Analysis: Unpacking a 12.75% Potential Upside

Individual investors seeking opportunities in the technology sector should consider Donnelley Financial Solutions, Inc. (NYSE: DFIN), a company that specializes in innovative software and technology-enabled financial regulatory and compliance solutions...

Viant Technology Inc. (DSP) Stock Analysis: Exploring a Promising 60.75% Potential Upside

As the digital advertising landscape continues to evolve, Viant Technology Inc. (DSP) is capturing the attention of investors with a potent combination of cutting-edge technology, robust growth metrics, and a..

Neurogene Inc. (NGNE) Investor Outlook: Potential Upside of 118.56% with Strong Buy Ratings

Neurogene Inc. (NASDAQ: NGNE), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on developing genetic medicines for rare neurological diseases. Headquartered in New York..

Kingsoft Cloud Holdings Limited (KC) Stock Analysis: Unpacking the 25% Potential Upside

For investors eyeing opportunities in the technology sector, Kingsoft Cloud Holdings Limited (NASDAQ: KC) presents an intriguing proposition with a potential upside of 25.16%, according to analyst ratings. Despite its..

SmartRent, Inc. (SMRT) Stock Analysis: Evaluating a 60% Potential Upside in the Tech Sector

SmartRent, Inc. (NASDAQ: SMRT) is gaining attention in the technology sector, specifically within the software application industry. As a provider of innovative real estate technology solutions, SmartRent is known for..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a $265 Million Market Cap in Veterinary Vaccines

Zhengye Biotechnology Holding L (ZYBT) presents a unique opportunity in the healthcare sector, particularly in the niche industry of veterinary vaccines. With a market capitalization of $265.39 million, Zhengye Biotechnology..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Navigating a Promising Pipeline with a 5.11% Potential Upside

iTeos Therapeutics, Inc. (NASDAQ: ITOS) sits at the intersection of biotechnology and innovation, offering a compelling proposition for investors with its focus on pioneering immuno-oncology therapeutics. Headquartered in Watertown, Massachusetts,..

Asure Software Inc (ASUR) Stock Analysis: Unveiling a 48% Potential Upside for Investors

Asure Software Inc (NASDAQ: ASUR), a key player in the technology sector, is gaining attention for its promising potential upside. With its headquarters nestled in Austin, Texas, Asure Software specializes..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: A 61.97% Potential Upside Worth Watching

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Fremont, California, Cytek Biosciences is renowned for its..

Uber Technologies, Inc. (UBER) Stock Analysis: Riding High with a 14.72% Potential Upside

For investors with a keen eye on the technology sector, Uber Technologies, Inc. (NYSE: UBER) presents a compelling opportunity as it continues to make significant strides in the global market...

Triller Group Inc. (ILLR) Stock Analysis: Can This Tech Underdog Overcome Its Financial Hurdles?

Triller Group Inc. (ILLR) is navigating the competitive landscape of the technology sector, specifically within the software application industry. With a market capitalization of $90.18 million, this Los Angeles-based company..

Tvardi Therapeutics, Inc. (TVRD): Investor Outlook on Its 119.65% Potential Upside

Tvardi Therapeutics, Inc. (NASDAQ: TVRD) is making waves in the biotechnology sector with its promising pipeline of small molecule therapies. The clinical-stage biopharmaceutical company, headquartered in Sugar Land, Texas, is..

Freshworks Inc. (FRSH) Investor Outlook: Impressive 52.49% Potential Upside Amid Strong Buy Ratings

Freshworks Inc. (NASDAQ: FRSH), a prominent player in the technology sector, is capturing the attention of investors with its impressive potential upside of 52.49%, according to analyst ratings. This software-as-a-service..

Docebo Inc. (DCBO) Stock Analysis: Growth Potential with 28% Upside for Tech-Savvy Investors

For investors with an eye on the technology sector, Docebo Inc. (NASDAQ: DCBO) presents a compelling opportunity. As a leading player in the software-application industry, Docebo is gaining attention for..

Blend Labs, Inc. (BLND) Investor Outlook: Unveiling a 49% Potential Upside in the Fintech Market

Blend Labs, Inc. (NYSE: BLND) is standing out as a compelling prospect for investors focused on the intersection of technology and financial services. With a market capitalization of approximately $868.64..

Search

Funds

July 31, 2025

Search

Funds

July 31, 2025

FTSE 100

Funds